PATENT CLAIM ANALYSIS

Application Number: 16016290
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "217050"]

Abstract:
Provided herein are compounds that activate CFTR and methods for treating constipation, dry eye disorders, and other diseases and disorders.

Claim (Index 13):
The compound of  claim 6  or  7 , wherein R 3  and R 4  are independently hydrogen, methyl or ethyl.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 94.0
- Lexical Diversity: 1.21053
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15662861', '15700040', '15757238', '15214282', '15760959']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8670145849222443
- 35 USC 102 Novelty (BERT): 0.6408720848224789
- Combined Prediction Score: 0.8444003349122677
- Mean Citation Score: 616.71942
- Max Citation Score: 802.6446
- Similarity Product: 550.8883659353613

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test